Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

biocryst - peramivir - Γρίπη, Ανθρώπινα - Αντιιικά για συστηματική χρήση - alpivab ενδείκνυται για τη θεραπεία της απλή γρίπης σε ενήλικες και παιδιά από την ηλικία των 2 ετών.

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

lohmann animal health gmbh & co kg. (0000008361) heinz-lohmann str, 4, cuxhaven, d-27472 - infectious bursal disease virus, strain cu 1m - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΓΙΑ ΕΝΕΩΡΗΜΑ - infectious bursal disease virus, strain cu 1m (8900000042) 0eid50 - avian infectious bursal disease virus (gumboro disease)

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

lohmann animal health gmbh & co kg. (0000008361) heinz-lohmann str, 4, cuxhaven, d-27472 - live apathogenic turkey herpes virus, strain fc 126 - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΓΙΑ ΕΝΕΩΡΗΜΑ - live apathogenic turkey herpes virus, strain fc 126 (8900000251) 0mg - avian herpes virus (mareks disease)

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - Κοτόπουλο - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

lohmann animal health gmbh & co kg. (0000008361) heinz-lohmann str, 4, cuxhaven, d-27472 - live infectious bronchitis virus, strain massachusettes h 120 - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΓΙΑ ΕΝΕΩΡΗΜΑ - live infectious bronchitis virus, strain massachusettes h 120 (8900000043) 0eid50 - avian infectious bronchitis virus

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

lohmann animal health gmbh & co kg. (0000008361) heinz-lohmann str, 4, cuxhaven, d-27472 - infectious bursal virus, strain lc-75 - powder for oral suspension - infectious bursal virus, strain lc-75 (8900000002) 1000eid50 - avian infectious bursal disease virus (gumboro disease), vaccines for poultry

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

biotest pharma gmbh, germany landsteinerstraße 5, 63303 dreieich +49(0) 6103 801-0 - immunoglobulin human anti-cytomegalo-virus - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - 100 u/ml - immunoglobulin human anti-cytomegalo-virus 100u - cytomegalovirus immunoglobulin

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

intervet hellas ae (0000001815) Αγ. Δημητρίου 63,,174 56,174 56, Αλιμος,gr - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - equine rhinopneumonitis virus + equine influenza virus ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - equine rhinopneumonitis virus + equine influenza virus - Άλογα - Χρόνοι αναμονής: Άλογα